Dextranomer beads in stabilized non-animal sodium hyaluronate gel (nasha™/dx gel) for vesicoureteral reflux

Multi-center study in Japanease patients

Saburo Tanikaze, Yuichi Osa, Minoru Tada, Nobuyuki Goya, Hiroshi Asanuma, Yuichiro Yamazaki, Kenji Shimada, Yoshifumi Sugita, Takafumi Goto, Takanori Yamaguchi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

(Purpose) To investigate the efficacy and safety of endoscopic treatment with the injectable gel of dextranomer beads in stabilized non-animal sodium hyaluronate (NASHA™/Dx gel) administered submucosally close to the proximity of ureteral orifice, we performed the multi-center open study of Japanese patients with vesicoureteral reflux (VUR). We herein report the results of the study. (Subjects and methods) Patients aged ≥ 1 year with grade H-IV VUR underwent endoscopic injection with NASHA/Dx gel. Post-treatment assessment was done by voiding cystourethrography (VCUG) at 3 and 12 months. Patients with VUR grade II-IV at 3 months underwent re-treatment, with VCUG assessment 3 and 12 months after retreatment. Positive response to treatment was defined as reflux grade 0 or I. (Results) The initial treatment was conducted to 116 ureters in 73 patients. The per-protocol efficacy population included 97 ureters in 71 patients. On a per-ureter basis, the positive response rate at 12 months after the last endoscopic treatment was 69.1%, compared with 62.0% on a per-patient basis. Improvement in reflux grade was shown to be statistically significant at both 3 months post initial treatment and 12 months post last treatment. Positive response rate decreased with increasing baseline reflux grade. There were only two mild adverse events (AEs) and one moderate laboratory fluctuation which were potentially relating to NASHA/Dx gel. (Conclusions) This study has shown that endoscopic injection of NASHA/Dx gel is effective and well tolerated in Japanese patients with VUR. First-line use of this treatment for VUR could potentially be considered for Japan also.

Original languageEnglish
Pages (from-to)676-682
Number of pages7
JournalJapanese Journal of Urology
Volume101
Issue number5
Publication statusPublished - 2010 Jul

Fingerprint

Vesico-Ureteral Reflux
Hyaluronic Acid
Gels
Ureter
Therapeutics
Injections
dextranomer
Retreatment
Japan
Safety

Keywords

  • Endoscopic injection therapy
  • NASHA/Dx gel
  • Vesicoureteral reflux

ASJC Scopus subject areas

  • Urology
  • Medicine(all)

Cite this

Dextranomer beads in stabilized non-animal sodium hyaluronate gel (nasha™/dx gel) for vesicoureteral reflux : Multi-center study in Japanease patients. / Tanikaze, Saburo; Osa, Yuichi; Tada, Minoru; Goya, Nobuyuki; Asanuma, Hiroshi; Yamazaki, Yuichiro; Shimada, Kenji; Sugita, Yoshifumi; Goto, Takafumi; Yamaguchi, Takanori.

In: Japanese Journal of Urology, Vol. 101, No. 5, 07.2010, p. 676-682.

Research output: Contribution to journalArticle

Tanikaze, S, Osa, Y, Tada, M, Goya, N, Asanuma, H, Yamazaki, Y, Shimada, K, Sugita, Y, Goto, T & Yamaguchi, T 2010, 'Dextranomer beads in stabilized non-animal sodium hyaluronate gel (nasha™/dx gel) for vesicoureteral reflux: Multi-center study in Japanease patients', Japanese Journal of Urology, vol. 101, no. 5, pp. 676-682.
Tanikaze, Saburo ; Osa, Yuichi ; Tada, Minoru ; Goya, Nobuyuki ; Asanuma, Hiroshi ; Yamazaki, Yuichiro ; Shimada, Kenji ; Sugita, Yoshifumi ; Goto, Takafumi ; Yamaguchi, Takanori. / Dextranomer beads in stabilized non-animal sodium hyaluronate gel (nasha™/dx gel) for vesicoureteral reflux : Multi-center study in Japanease patients. In: Japanese Journal of Urology. 2010 ; Vol. 101, No. 5. pp. 676-682.
@article{4955de1575c847f9b449a0699b6c6635,
title = "Dextranomer beads in stabilized non-animal sodium hyaluronate gel (nasha™/dx gel) for vesicoureteral reflux: Multi-center study in Japanease patients",
abstract = "(Purpose) To investigate the efficacy and safety of endoscopic treatment with the injectable gel of dextranomer beads in stabilized non-animal sodium hyaluronate (NASHA™/Dx gel) administered submucosally close to the proximity of ureteral orifice, we performed the multi-center open study of Japanese patients with vesicoureteral reflux (VUR). We herein report the results of the study. (Subjects and methods) Patients aged ≥ 1 year with grade H-IV VUR underwent endoscopic injection with NASHA/Dx gel. Post-treatment assessment was done by voiding cystourethrography (VCUG) at 3 and 12 months. Patients with VUR grade II-IV at 3 months underwent re-treatment, with VCUG assessment 3 and 12 months after retreatment. Positive response to treatment was defined as reflux grade 0 or I. (Results) The initial treatment was conducted to 116 ureters in 73 patients. The per-protocol efficacy population included 97 ureters in 71 patients. On a per-ureter basis, the positive response rate at 12 months after the last endoscopic treatment was 69.1{\%}, compared with 62.0{\%} on a per-patient basis. Improvement in reflux grade was shown to be statistically significant at both 3 months post initial treatment and 12 months post last treatment. Positive response rate decreased with increasing baseline reflux grade. There were only two mild adverse events (AEs) and one moderate laboratory fluctuation which were potentially relating to NASHA/Dx gel. (Conclusions) This study has shown that endoscopic injection of NASHA/Dx gel is effective and well tolerated in Japanese patients with VUR. First-line use of this treatment for VUR could potentially be considered for Japan also.",
keywords = "Endoscopic injection therapy, NASHA/Dx gel, Vesicoureteral reflux",
author = "Saburo Tanikaze and Yuichi Osa and Minoru Tada and Nobuyuki Goya and Hiroshi Asanuma and Yuichiro Yamazaki and Kenji Shimada and Yoshifumi Sugita and Takafumi Goto and Takanori Yamaguchi",
year = "2010",
month = "7",
language = "English",
volume = "101",
pages = "676--682",
journal = "Japanese Journal of Urology",
issn = "0021-5287",
publisher = "Japanese Urological Association",
number = "5",

}

TY - JOUR

T1 - Dextranomer beads in stabilized non-animal sodium hyaluronate gel (nasha™/dx gel) for vesicoureteral reflux

T2 - Multi-center study in Japanease patients

AU - Tanikaze, Saburo

AU - Osa, Yuichi

AU - Tada, Minoru

AU - Goya, Nobuyuki

AU - Asanuma, Hiroshi

AU - Yamazaki, Yuichiro

AU - Shimada, Kenji

AU - Sugita, Yoshifumi

AU - Goto, Takafumi

AU - Yamaguchi, Takanori

PY - 2010/7

Y1 - 2010/7

N2 - (Purpose) To investigate the efficacy and safety of endoscopic treatment with the injectable gel of dextranomer beads in stabilized non-animal sodium hyaluronate (NASHA™/Dx gel) administered submucosally close to the proximity of ureteral orifice, we performed the multi-center open study of Japanese patients with vesicoureteral reflux (VUR). We herein report the results of the study. (Subjects and methods) Patients aged ≥ 1 year with grade H-IV VUR underwent endoscopic injection with NASHA/Dx gel. Post-treatment assessment was done by voiding cystourethrography (VCUG) at 3 and 12 months. Patients with VUR grade II-IV at 3 months underwent re-treatment, with VCUG assessment 3 and 12 months after retreatment. Positive response to treatment was defined as reflux grade 0 or I. (Results) The initial treatment was conducted to 116 ureters in 73 patients. The per-protocol efficacy population included 97 ureters in 71 patients. On a per-ureter basis, the positive response rate at 12 months after the last endoscopic treatment was 69.1%, compared with 62.0% on a per-patient basis. Improvement in reflux grade was shown to be statistically significant at both 3 months post initial treatment and 12 months post last treatment. Positive response rate decreased with increasing baseline reflux grade. There were only two mild adverse events (AEs) and one moderate laboratory fluctuation which were potentially relating to NASHA/Dx gel. (Conclusions) This study has shown that endoscopic injection of NASHA/Dx gel is effective and well tolerated in Japanese patients with VUR. First-line use of this treatment for VUR could potentially be considered for Japan also.

AB - (Purpose) To investigate the efficacy and safety of endoscopic treatment with the injectable gel of dextranomer beads in stabilized non-animal sodium hyaluronate (NASHA™/Dx gel) administered submucosally close to the proximity of ureteral orifice, we performed the multi-center open study of Japanese patients with vesicoureteral reflux (VUR). We herein report the results of the study. (Subjects and methods) Patients aged ≥ 1 year with grade H-IV VUR underwent endoscopic injection with NASHA/Dx gel. Post-treatment assessment was done by voiding cystourethrography (VCUG) at 3 and 12 months. Patients with VUR grade II-IV at 3 months underwent re-treatment, with VCUG assessment 3 and 12 months after retreatment. Positive response to treatment was defined as reflux grade 0 or I. (Results) The initial treatment was conducted to 116 ureters in 73 patients. The per-protocol efficacy population included 97 ureters in 71 patients. On a per-ureter basis, the positive response rate at 12 months after the last endoscopic treatment was 69.1%, compared with 62.0% on a per-patient basis. Improvement in reflux grade was shown to be statistically significant at both 3 months post initial treatment and 12 months post last treatment. Positive response rate decreased with increasing baseline reflux grade. There were only two mild adverse events (AEs) and one moderate laboratory fluctuation which were potentially relating to NASHA/Dx gel. (Conclusions) This study has shown that endoscopic injection of NASHA/Dx gel is effective and well tolerated in Japanese patients with VUR. First-line use of this treatment for VUR could potentially be considered for Japan also.

KW - Endoscopic injection therapy

KW - NASHA/Dx gel

KW - Vesicoureteral reflux

UR - http://www.scopus.com/inward/record.url?scp=77955873717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955873717&partnerID=8YFLogxK

M3 - Article

VL - 101

SP - 676

EP - 682

JO - Japanese Journal of Urology

JF - Japanese Journal of Urology

SN - 0021-5287

IS - 5

ER -